Press Release Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald 14 hours ago
Press Release Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates Aug 17